Variant report

Variant	nsv968878
Chromosome Location	chr5:17060812-17067987
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:56)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:56 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr5:17062157-17062626	A549	lung:	n/a	n/a
2	CREB1	chr5:17062191-17062636	A549	lung:	n/a	n/a
3	CTCF	chr5:17062309-17062609	A549	lung:	n/a	n/a
4	CTCF	chr5:17062342-17062592	K562	blood:	n/a	n/a
5	CTCF	chr5:17062360-17062510	GM12865	blood:	n/a	n/a
6	CTCF	chr5:17062308-17062564	A549	lung:	n/a	n/a
7	CTCF	chr5:17064460-17064610	HCPEpiC	choroid plexus:	n/a	n/a
8	CTCF	chr5:17062360-17062510	HepG2	liver:	n/a	n/a
9	CTCF	chr5:17062440-17062479	HUVEC	blood vessel:	n/a	n/a
10	CTCF	chr5:17061917-17062776	A549	lung:	n/a	n/a
11	CTCF	chr5:17062160-17062310	HAc	cerebellar:	n/a	n/a
12	CTCF	chr5:17062316-17062617	A549	lung:	n/a	n/a
13	CTCF	chr5:17062380-17062530	HBMEC	blood vessel:	n/a	n/a
14	CTCF	chr5:17062438-17062486	Pancreas_OC	pancreas:	n/a	n/a
15	CTCF	chr5:17062400-17062550	NHEK	skin:	n/a	n/a
16	CTCF	chr5:17062360-17062510	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr5:17062383-17062519	K562	blood:	n/a	n/a
18	CTCF	chr5:17062258-17062667	A549	lung:	n/a	n/a
19	CTCF	chr5:17062441-17062509	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr5:17062360-17062510	HCFaa	heart:	n/a	n/a
21	CTCF	chr5:17062380-17062530	K562	blood:	n/a	n/a
22	CTCF	chr5:17062340-17062490	WI-38	lung:	n/a	n/a
23	CTCF	chr5:17062300-17062535	A549	lung:	n/a	n/a
24	CTCF	chr5:17062420-17062570	GM12868	blood:	n/a	n/a
25	CTCF	chr5:17062340-17062490	A549	lung:	n/a	n/a
26	CTCF	chr5:17062360-17062510	HEEpiC	esophagus:	n/a	n/a
27	CTCF	chr5:17062360-17062510	HAc	cerebellar:	n/a	n/a
28	CTCF	chr5:17062360-17062510	K562	blood:	n/a	n/a
29	CTCF	chr5:17062380-17062530	A549	lung:	n/a	n/a
30	CTCF	chr5:17062380-17062530	HCPEpiC	choroid plexus:	n/a	n/a
31	CTCF	chr5:17062400-17062550	HAc	cerebellar:	n/a	n/a
32	E2F6	chr5:17061946-17062624	A549	lung:	n/a	n/a
33	E2F6	chr5:17062159-17062542	A549	lung:	n/a	n/a
34	FOSL2	chr5:17062320-17062538	A549	lung:	n/a	n/a
35	FOSL2	chr5:17067743-17068158	MCF-7	breast:	n/a	chr5:17067913-17067921
36	FOXA1	chr5:17064545-17064853	T-47D	breast:	n/a	chr5:17064704-17064719
37	GATA3	chr5:17067780-17068115	MCF-7	breast:	n/a	n/a
38	GATA3	chr5:17067741-17068319	A549	lung:	n/a	n/a
39	JUND	chr5:17062257-17062645	A549	lung:	n/a	n/a
40	MAX	chr5:17061967-17062708	A549	lung:	n/a	n/a
41	MAX	chr5:17062228-17062513	A549	lung:	n/a	n/a
42	MAX	chr5:17061993-17062687	A549	lung:	n/a	n/a
43	NFYA	chr5:17062897-17063311	K562	blood:	n/a	chr5:17063057-17063075
44	NFYB	chr5:17062736-17063395	K562	blood:	n/a	chr5:17063054-17063069 chr5:17063013-17063028
45	NFYB	chr5:17062896-17063329	Hela-S3	cervix:	n/a	chr5:17063054-17063069 chr5:17063013-17063028
46	NFYB	chr5:17062902-17063302	GM12878	blood:	n/a	chr5:17063054-17063069 chr5:17063013-17063028
47	POLR2A	chr5:17062134-17062680	A549	lung:	n/a	n/a
48	POLR2A	chr5:17062130-17062368	A549	lung:	n/a	n/a
49	RAD21	chr5:17062126-17062691	A549	lung:	n/a	n/a
50	RAD21	chr5:17062420-17062470	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:17062511-17062561	SK-N-MC	brain:	n/a
2	chr5:17062511-17062561	NHBE	bronchial:	n/a
3	chr5:17062511-17062561	Hepatocyte	liver:	n/a
4	chr5:17062511-17062561	HCM	heart:	n/a
5	chr5:17062511-17062561	AG09309	skin:	n/a
6	chr5:17062511-17062561	SK-N-SH_RA	brain:	n/a
7	chr5:17062511-17062561	HRE	kidney:	n/a
8	chr5:17062511-17062561	PrEC	prostate:	n/a
9	chr5:17062511-17062561	RPTEC	kidney:	n/a
10	chr5:17062511-17062561	AG04450	lung:	fetal
11	chr5:17062511-17062561	HUVEC	blood vessel:	n/a
12	chr5:17062511-17062561	HNPCEpiC	eye:	n/a
13	chr5:17062511-17062561	PFSK-1	brain:	n/a
14	chr5:17062511-17062561	AG04449	skin:	fetal
15	chr5:17062511-17062561	HCF	heart:	n/a
16	chr5:17062511-17062561	T-47D	breast:	n/a
17	chr5:17062511-17062561	HCT-116	colon:	n/a
18	chr5:17062511-17062561	ovcar-3	ovarian:	n/a
19	chr5:17062511-17062561	GM06990	blood:	n/a
20	chr5:17062511-17062561	HMEC	breast:	n/a
21	chr5:17062511-17062561	PANC-1	pancreas:	n/a
22	chr5:17062511-17062561	GM19239	blood:	n/a
23	chr5:17062511-17062561	HIPEpiC	eye:	n/a
24	chr5:17062511-17062561	SKMC	muscle:	n/a
25	chr5:17062511-17062561	CMK	blood:	n/a
26	chr5:17062511-17062561	IMR90	lung:	fetal
27	chr5:17062511-17062561	MCF10A-Er-Src	breast:	n/a
28	chr5:17062511-17062561	LNCaP	prostate:	n/a
29	chr5:17062511-17062561	HAEpiC	amniotic membrane:	n/a
30	chr5:17062511-17062561	Caco-2	colon:	n/a
31	chr5:17062511-17062561	U87	brain:	n/a
32	chr5:17062511-17062561	NHDF-neo	bronchial:	n/a
33	chr5:17062511-17062561	NT2-D1	testis:	n/a
34	chr5:17062511-17062561	BE2_C	brain:	n/a
35	chr5:17062511-17062561	NB4	blood:	n/a
36	chr5:17062511-17062561	MCF-7	breast:	n/a
37	chr5:17062511-17062561	Jurkat	blood:	n/a
38	chr5:17062511-17062561	A549	lung:	n/a
39	chr5:17062511-17062561	SK-N-SH	brain:	n/a
40	chr5:17062511-17062561	HL-60	blood:	n/a
41	chr5:17062511-17062561	GM12892	blood:	n/a
42	chr5:17062511-17062561	HRPEpiC	eye:	n/a
43	chr5:17062511-17062561	ECC-1	luminal epithelium:	n/a
44	chr5:17062511-17062561	GM12878	blood:	n/a
45	chr5:17062511-17062561	ProgFib	skin:	n/a
46	chr5:17062511-17062561	AG10803	skin:	n/a
47	chr5:17062511-17062561	HEEpiC	esophagus:	n/a
48	chr5:17062511-17062561	AoSMC	blood vessel:	n/a
49	chr5:17062511-17062561	K562	blood:	n/a
50	chr5:17062511-17062561	GM12891	blood:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:17055618..17058211-chr5:17065724..17068403,2	K562	blood:
2	chr5:16934962..16937579-chr5:17059842..17062235,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BASP1-2	chr5:17065660-17065809	XLOC_004306
2	lnc-BASP1-2	chr5:17065660-17065809	XLOC_004306
3	lnc-BASP1-2	chr5:17063337-17063762	XLOC_004306
4	lnc-BASP1-2	chr5:17063337-17063762	XLOC_004306

No data

Variant related genes	Relation type
BASP1	TF binding region
BASP1	CpG island
ENSG00000145555	chromatin interactions

Extended variants
information (count: 513 )
Associated
traits (count: 94 )

Variant overlapped rSNPs/rCNVs (count:513 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs544749788	chr5:17060818-17060819	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs553525729	chr5:17060835-17060836	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs190298920	chr5:17060895-17060896	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs117777079	chr5:17060954-17060955	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs200408462	chr5:17060969-17060970	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs368099330	chr5:17061063-17061064	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs74729775	chr5:17061064-17061065	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs207465640	chr5:17061080-17061081	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs557507063	chr5:17061083-17061084	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs528114242	chr5:17061110-17061111	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs575985154	chr5:17061198-17061199	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs558276638	chr5:17061233-17061234	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs576657610	chr5:17061234-17061235	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs148791833	chr5:17061235-17061236	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs538181245	chr5:17061288-17061289	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs556879728	chr5:17061436-17061437	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs377641713	chr5:17061439-17061440	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs370494645	chr5:17061463-17061464	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs575151719	chr5:17061481-17061482	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs181432896	chr5:17061485-17061486	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs560621451	chr5:17061508-17061509	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs111842474	chr5:17061509-17061510	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs546277202	chr5:17061510-17061511	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs564353218	chr5:17061518-17061519	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs531716808	chr5:17061528-17061529	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs559768119	chr5:17061552-17061553	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs34253513	chr5:17061558-17061559	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs186256542	chr5:17061583-17061584	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs561671817	chr5:17061586-17061587	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs529108231	chr5:17061618-17061619	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs551640183	chr5:17061635-17061636	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs189162157	chr5:17061639-17061640	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs565855961	chr5:17061696-17061697	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs539203430	chr5:17061704-17061705	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs3860140	chr5:17061726-17061727	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs569581154	chr5:17061731-17061732	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs537059436	chr5:17061739-17061740	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs2086606	chr5:17061742-17061743	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs2086607	chr5:17061805-17061806	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs35260137	chr5:17061844-17061845	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs180980071	chr5:17061872-17061873	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs186006172	chr5:17061891-17061892	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs4327598	chr5:17061899-17061900	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs191329595	chr5:17061915-17061916	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs60609082	chr5:17061927-17061928	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs576433706	chr5:17061932-17061933	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs550977293	chr5:17061974-17061975	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs565063837	chr5:17062011-17062012	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs543417755	chr5:17062020-17062021	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs561708526	chr5:17062029-17062030	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:94)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:44 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:17056600-17062200	Weak transcription	Placenta	Placenta
2	chr5:17056800-17062200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr5:17056800-17064600	Weak transcription	Ovary	ovary
4	chr5:17058000-17061800	Enhancers	A549	lung
5	chr5:17058200-17061800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
6	chr5:17058400-17061800	Weak transcription	Fetal Stomach	stomach
7	chr5:17060000-17062200	Weak transcription	Gastric	stomach
8	chr5:17060000-17068200	Weak transcription	Stomach Mucosa	stomach
9	chr5:17061200-17061400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr5:17061800-17062200	Enhancers	Fetal Stomach	stomach
11	chr5:17061800-17062200	Flanking Active TSS	A549	lung
12	chr5:17061800-17062400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
13	chr5:17062200-17062400	Enhancers	Gastric	stomach
14	chr5:17062200-17062600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr5:17062200-17062600	Active TSS	A549	lung
16	chr5:17062200-17062800	Enhancers	Placenta	Placenta
17	chr5:17062600-17064200	Weak transcription	A549	lung
18	chr5:17062600-17066800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr5:17062800-17063000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
20	chr5:17063400-17063600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr5:17063600-17063800	Enhancers	Primary hematopoietic stem cells short term culture	blood
22	chr5:17063600-17064600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr5:17063600-17064800	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr5:17063600-17068200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr5:17063800-17066400	Enhancers	Fetal Lung	lung
26	chr5:17064000-17065200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr5:17064200-17064800	Enhancers	Fetal Kidney	kidney
28	chr5:17064200-17064800	Enhancers	Pancreatic Islets	Pancreatic Islet
29	chr5:17064200-17065000	Enhancers	A549	lung
30	chr5:17064400-17064800	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr5:17064600-17065800	Enhancers	Ovary	ovary
32	chr5:17064600-17070000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
33	chr5:17064800-17065800	Weak transcription	HUES6 Cell Line	embryonic stem cell
34	chr5:17064800-17066200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
35	chr5:17065000-17068000	Weak transcription	A549	lung
36	chr5:17065200-17067200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr5:17065600-17066000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr5:17065800-17066600	Enhancers	HUES6 Cell Line	embryonic stem cell
39	chr5:17065800-17069600	Weak transcription	Ovary	ovary
40	chr5:17066000-17069600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
41	chr5:17066200-17066400	Enhancers	ES-I3 Cell Line	embryonic stem cell
42	chr5:17066400-17069600	Weak transcription	Fetal Lung	lung
43	chr5:17067200-17068200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr5:17067800-17068400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links